|4Jan 10, 7:19 PM ET

Branning Todd P. 4

4 · NeuBase Therapeutics, Inc. · Filed Jan 10, 2022

Insider Transaction Report

Form 4
Period: 2022-01-10
Branning Todd P.
Chief Financial Officer
Transactions
  • Award

    Employee stock option (right to buy)

    2022-01-10+300,000300,000 total
    Exercise: $2.52Exp: 2032-01-10Common stock (300,000 underlying)
Footnotes (1)
  • [F1]1/4th of the total shares shall vest on the first anniversary of the effective date of employment, and 1/36th of the remaining shares shall vest on a monthly basis starting on the first anniversary of the effective date of employment; provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date, inclusive.

Documents

1 file
  • 4
    tm222244d2_4.xmlPrimary

    OWNERSHIP DOCUMENT